Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart scan report prompts aim to boost specialist referrals

NCT ID NCT06816888

Ongoing Knowledge-focused Sponsor: Ottawa Heart Institute Research Corporation Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding automatic reminders to echocardiogram (heart ultrasound) reports can increase the number of patients with heart valve disease who see a cardiologist within six months. Researchers will randomly assign 300 patients' reports to receive no prompt, a prompt suggesting a cardiology referral, or a prompt that also offers help from a specialized heart center. The goal is to see if these simple nudges improve care without changing any medical treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
automatic prompts in echocardiographic reports
What this could lead to
If it works, this could show a simple way to improve care for people with heart valve disease by helping doctors refer them to a heart specialist sooner.
What could go wrong
This is a small, early-stage study testing a process change, not a new treatment. The prompts may not change doctor behavior, and results may not apply to all hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MITRAL REGURGITATION (MR) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aortic valve stenosis follicular lymphoma heart valve disorder mitral valve insufficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MITRAL REGURGITATION (MR) MODERATE OR SEVERE AORTIC STENOSIS (AS) (MEAN PRESSURE GRADIENT ≥ 20 MM HG OR AORTIC VALVE AREA ≤ 1.5 CM2)

Contacts and locations

Locations

  • University of Ottawa Heart Institute

    Ottawa, Ontario, K1Y 4W7, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.